A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a ...

HHS is tasked with communicating information to protect and improve the health and well-being of every American. It provides ...

"These findings are a reminder that people with epilepsy are searching for answers in online spaces every day," said Douglas ...

Patients with <7/8 transplants had a 1-year survival of 85.6% versus 78.6% for those who received better-matched donor cells.

They don't seek medical care first, but find solace in stories and role models who seem to "get it." But often, the ...

"One of the most serious public health challenges of our time." -- World Health Organization Director-General Tedros Adhanom ...

The aim of the fixed-duration approach is to "produce deep remissions and thereby allow patients to get off therapy while ...

"Epcoritamab and R 2 is a novel chemotherapy-free fixed-duration therapy that is suitable for outpatient administration and, we believe, sets a new benchmark as a standard of care for second-line [or ...

Neflamapimod is an oral p38 alpha kinase inhibitor that targets dysfunction and degeneration of acetylcholine-producing ...

Exa-cel is the first FDA-approved therapy utilizing CRISPR/Cas9, a type of gene editing technology through which patients' ...

In a sharp break from more than three decades of U.S. vaccine policy, a CDC advisory panel voted Friday to stop recommending ...